title: Cytokines in patients with lung cancer.
abstract: Lung cancer is one of the most common malignant diseases and is amongst the leading causes of death. Cell-mediated immune response and cytokines could play an important role in antitumour immunity. The aim of the study was to evaluate the cytokines', tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and IL-6, releasing capacity in patients with lung carcinoma and benign lung disease. A group of 41 patients were tested for the production of TNF-alpha, IL-1beta and IL-6 in bronchoalveolar lavage (BAL) and blood. The levels of cytokines in the lung cancer patients were: (1) in BAL - IL-6, 173 +/- 85 pg/ml; TNF-alpha, 170 +/- 116 pg/ml; and IL-1beta, 473 +/- 440 pg/ml; (2) in the blood - IL-6, 197 +/- 53 pg/ml; TNF-alpha, 311 +/- 202 pg/ml; and IL-1beta, 915 +/- 239 pg/ml. Alveolar macrophages of the patients with a lung cancer secreted significantly more cytokines, IL-6 (P = 0.0004) and IL-1beta (P = 0.0047), than alveolar macrophages of the patients with a nonmalignant lung cancer. However, significantly lower levels of cytokine production by the BAL cells were found in patients with small cell lung cancer. This production decreased further in phase IV of nonsmall cell lung cancer.
authors.affiliation: Clinic for Internal Medicine, Pneumology Department, Clinical Hospital Centre Rijeka, Rijeka, Croatia. dubravkama@net.hr
authors.forename: D
authors.initials: D
authors.lastname: Matanić
authors.forename: Z
authors.initials: Z
authors.lastname: Beg-Zec
authors.forename: D
authors.initials: D
authors.lastname: Stojanović
authors.forename: N
authors.initials: N
authors.lastname: Matakorić
authors.forename: V
authors.initials: V
authors.lastname: Flego
authors.forename: F
authors.initials: F
authors.lastname: Milevoj-Ribić
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology* / Q000378:metabolism; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis* / Q000276:immunology; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis / Q000097:blood; D015850:Interleukin-6 / Q000097:blood / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology* / Q000378:metabolism; D016676:Macrophages, Alveolar / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha